INJE PharmacoGenomics Research Center

· Bu F, Cho YS, He Q, Wang X, Howlader S, Kim DH, Zhu M, Shin JG, Xiang X

Prediction of Pharmacokinetic Drug-Drug Interactions Involving Anlotinib as a Victim by Using Physiologically Based Pharmacokinetic Modeling (cPMTb)

Drug Des Devel Ther. 15:18:4585-4600 / 2024.10 [LINK]

· Phat NK, Tien NTM, Anh NK, Yen NTH, Lee YA, Trinh HKT, Le KM, Ahn SZ, Cho YS, Park SO, Kim DH, Long NP, Shin JG

Alterations of lipid-related genes during anti-tuberculosis treatment: insights into host immune responses and potential transcriptional biomarkers (cPMTb)

Front Immunol. 31:14:1210372 / 2023.10 [LINK]

· Yen NTH, Phat NK, Oh JH, Park SM, Moon KS, Thu VTA, Cho YS, Shin JG, Long NP, Kim DH

Pathway-level multi-omics analysis of the molecular mechanisms underlying the toxicity of long-term tacrolimus exposure (cPMTb)

Toxicol Appl Pharmacol. 15:473:116597 / 2023.08 [LINK]

· Yen NTH, Anh NK, Jayanti RP, Phat NK, Vu DH, Ghim JL, Ahn SZ, Shin JG, Oh JY, Long NP, Kim DH

Multimodal plasma metabolomics and lipidomics in elucidating metabolic perturbations in tuberculosis patients with concurrent type 2 diabetes (cPMTb)

Biochimie. 211:153-163 / 2023.08 [LINK]

· Cho HY, Ahn SZ, Cho YS, Seo SK, Kim DH, Shin JG, Lee SJ

CYP2C19 Contributes to THP-1-Cell-Derived M2 Macrophage Polarization by Producing 11,12- and 14,15-Epoxyeicosatrienoic Acid, Agonists of the PPARγ Receptor (cPMTb)

Pharmaceuticals(Basel). 16(4):593 / 2023.04 [LINK]

· Anh NK, Phat NK, Yen NTH, Jayanti RP, Thu VTA, Park YJ, Cho YS, Shin JG, Kim DH, Oh JY, Long NP

Comprehensive lipid profiles investigation reveals host metabolic and immune alterations during anti-tuberculosis treatment: Implications for therapeutic monitoring (cPMTb)

Biomed Pharmacother. 158:114187 / 2023.02 [LINK]

· Anh NK, Tung PM, Kim MJ, Long NP, Cho YS, Kim DH, Shin JG

Quantitative Analysis of Isoniazid and Its Four Primary Metabolites in Plasma of Tuberculosis Patients Using LC-MS/MS (cPMTb)

Molecules. 27(23):8607 / 2022.12 [LINK]

· Le TK, Park YJ, Cha GS, Oktavia FARH, Kim DH, Yun CH

Roles of Human Liver Cytochrome P450 Enzymes in Tenatoprazole Metabolism (cPMTb)

Pharmaceutics. 15(1):23 / 2022.12 [LINK]

· Yen NTH, Park SM, Thu VTA, Phat NK, Cho YS, Yoon SJ, Shin JG, Kim DH, Oh JH, Long NP

Genome-wide gene expression analysis reveals molecular insights into the drug-induced toxicity of nephrotoxic agents (cPMTb)

Life Sci. 1:306:120801 / 2022.10 [LINK]

· Howlader S, Kim MJ, Jony MR, Long NP, Cho YS, Kim DH, Shin JG

Characterization of Clofazimine Metabolism in Human Liver Microsomal Incubation In Vitro (cPMTb)

Antimicrob Agents Chemother. 66(10):e0056522 / 2022.10 [LINK]

Publications

Product